24小时热门版块排行榜

返回列表

letdd

新虫 (初入文坛)

应助: 0 (幼儿园)
金币: 3
红花: 1
帖子: 25
在线: 4小时
虫号: 1968620
注册: 2012-09-02

[交流] JPBA 投稿被拒，贴出拒稿信，求指点已有5人参与

Dear Dr. Zhu,

I regret to inform you that, after consideration of our reviewers' comments on your paper (with which I fully agree), I'm unable to accept it for publication.

For your guidance, I append the reviewers' comments below.

Please note that a great many more papers are submitted to JPBA than we can possibly publish. The acceptance rate for papers is about 25% and our decision is not a reflection of the quality of your research but rather of our stringent requirements.

The Editors hope that you do understand the above decision, and we appreciate your continued interest in the Journal of Pharmaceutical and Biomedical Analysis.

Thank you for giving us the opportunity to consider your work. We wish you every success when you submit the paper elsewhere.

Yours sincerely,

Sándor Görög
Editor
Journal of Pharmaceutical and Biomedical Analysis

Reviewers' comments:

Reviewer #1: This paper is about Identification of major compounds in rat bile, plasma and urine after oral administration of Radix Scutellariae extract by ultra-fast liquid chromatography coupled to ion trap time-of-flight mass spectrometry.
Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in JPBA.
1. It is noted that your manuscript needs careful editing by someone with expertise in technical English editing paying particular attention to English grammar, spelling, and sentence structure.
2. The innovation of this manuscript is weak and the content of experiments is not plentiful.
3. The Fig.4 and Fig.4 are not clearly expressed, and the Fig.5 should be deleted. It will be nice if you can add the schematic diagram of the cracking.
Based on what was described above this manuscript is not suitable for publication in the journal of JPBA. We suggest that the authors try submitting their findings to other journals.

Reviewer #2: I do not recommend the publication of this manuscript due mainly to the lack of scientific novelty and for neglecting the comparison of the authors' method and results with those in the literature. The Guide for Authors of JPBA contains the following restriction: "In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods."
The authors have missed to make reference to closely related papers such as
Ling Tong, Meixu Wan, Lihua Zhang, Yonghong Zhu, He Sun, Kaishun Bi, Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis (2012) (from the same university!!!) and
Chung, H.J., Lim, S., Kim, I.S., Bu, Y., Kim, H., Kim, D.-H., Yoo, H.H., Simultaneous determination of baicalein, baicalin, wogonin, and wogonoside in rat plasma by LC-MS/MS for studying the pharmacokinetics of the standardized extract of scutellariae radix, Bulletin of the Korean Chemical Society, 33 (2012) 177-182.
Reference has been made to [23] but real comparison was not made.

回复此楼

» 猜你喜欢

谈谈两天一夜的“延安行” 已经有6人回复
博士申请都是内定的吗？已经有12人回复
氨基封端PDMS和HDI反应快速固化已经有11人回复
之前让一硕士生水了7个发明专利，现在这7个获批发明专利的维护费可从哪儿支出哈？已经有11人回复
论文投稿求助已经有4人回复
Applied Surface Science 这个期刊。有哪位虫友投过的能把word模板发给我参考一下嘛已经有3人回复
投稿精细化工已经有6人回复

» 本主题相关价值贴推荐，对您同样有帮助:

语言问题被拒两次投稿信怎么写已经有16人回复
投了一篇JPBA，三个月给拒了，编辑的拒信已经有43人回复
文章被拒，但想写申诉信，如何写？已经有21人回复
被拒了，想申诉呢，大家帮忙看看拒稿信，还有没有可能？已经有13人回复
有没有虫友被拒稿后写过申诉信？急需指点一下！已经有5人回复
JPBA 修稿，要求改图片格式，求助各位指点已经有3人回复
拒稿信还需要回复吗？已经有11人回复
发BB求助一份拒稿信已经有7人回复
文章被拒，求助被拒信中一段话的意思已经有12人回复
大家帮忙看下这封拒稿信是什么意思，还能继续投这个期刊吗？先谢谢各位了。已经有3人回复
看完拒稿信后的心情已经有37人回复
文章被拒，请大家帮我看看拒稿信，我应该怎么办？已经有31人回复
稿件被拒，打算回信力争已经有11人回复

1楼2012-09-02 11:53:34

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

独步青云

新虫 (职业作家)

术中小生

应助: 894 (博后)
金币: 2993.1
散金: 3834
红花: 16
帖子: 3587
在线: 241.8小时
虫号: 339818
注册: 2007-04-07
性别: GG
专业: 中药质量评价

★
小木虫: 金币+0.5, 给个红包，谢谢回帖

我仔细看了审稿意见。
首先不要再投JPBA了，通过几点老鼠，利用LC/MS进行简单地鉴定入血成分，自去年JPBA就不收了。随着IF的增长，其在代谢方面要求显著提高。
审稿人认为你的方法没有什么特色，换句话说你的发现没有什么闪光点。另外一定得和已报道文献进行比对，说明你方法的先进性。任何文章只报道自己东西，没有和先前文献对比的话，肯定是一短板。尤其遇到做过相关研究的审稿人，他认变你没有好好看文献。

赞一下

回复此楼

2楼2012-09-02 12:46:48

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

letdd

新虫 (初入文坛)

应助: 0 (幼儿园)
金币: 3
红花: 1
帖子: 25
在线: 4小时
虫号: 1968620
注册: 2012-09-02

引用回帖:

2楼: Originally posted by 独步青云 at 2012-09-02 12:46:48
我仔细看了审稿意见。
首先不要再投JPBA了，通过几点老鼠，利用LC/MS进行简单地鉴定入血成分，自去年JPBA就不收了。随着IF的增长，其在代谢方面要求显著提高。
审稿人认为你的方法没有什么特色，换句话说你的发现 ...

可能标题有误导，我做的代谢产物结构鉴定的。鉴定了20种代谢产物。和10种入血成分。

赞一下

回复此楼

3楼2012-09-06 13:26:40

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖